Spectrum Pharmaceuticals, Inc. to End Development of Enlarged-Prostate Drug; To Save More Than $40 Million from Termination

Reuters -- Spectrum Pharmaceuticals Inc said it will stop developing its experimental treatment for enlarged prostate to cut costs and focus on other drug candidates.